Glycolipid Meeting 2018
Hamburg, Friday, 01.06.2018
Location:
University of Hamburg
Faculty of Science, Department of Chemistry
Institute of Physical Chemistry
Grindelallee 117 (Verfügungsgebäude II, near to Martin-Luther-King-Platz)
Room 161
Martin-Luther-King-Platz 6
20146 Hamburg
Scientific Program:
First Session from 9:00 - 10:50
Chair: Klaus Brandenburg, Borstel9:00 - 9:15 Klaus Brandenburg, Forschungszentrum Borstel
Introductory remarks9:15 - 9:40 Günther Weindl, Institut für Pharmazie, Freie Universität Berlin
Novel modes of action for synthetic anti-lipopolysaccharide peptides: Inhibition of inflammasome activation and promotion of wound healing9:40 - 10:05 Wilmar Correa, Forschungszentrum Borstel, LG Biophysik
Analysis of the interaction between bacterial cell-wall toxins and synthetic anti-lipopolysaccharide peptides (SALP)10:05 - 10:30 Guillermo Martinez de Tejada, Universidad de Navarra, Pamplona
Exploring uncharted territory: novel properties of antimicrobial peptides with high therapeutic potential10:30 - 10:50 Karl Mauss, Asklepios Klinik Altona, Sektion plastische, ästhetische und rekonstruktive Chirurgie
Clinical study of skin and soft-tissue infections with Aspidasept10:50 - 11:10 Coffee Break
Second Session from 11:10 - 13:00
Chair: Klaus Brandenburg, Borstel11:10 - 11:35 Christian Herzmann, Forschungszentrum Borstel, Klinisches Studienzentrum
Tolerability and safety of Aspidasept® intravenously applicated in healthy males as microdose study according to ICH M3 (section 7.1)11:35 - 11:55 Sabrina Wohlfart, Universitätsklinikum Heidelberg, Radiopharmazeutische Chemie
The scientific basis for the preparation of a radiolabeled derivative of Aspidasept® to be used in a Phase 0 microdosing study11:55 - 12:15 Walter Mier, Universitätsklinikum Heidelberg
Synthesis and evaluation of novel glycopeptid-antibiotics12:15 - 12:35 N. N.
to be announced12:35 - 13:00 Cornelius Domhan, Universitätsklinikum Heidelberg, Radiopharmazeutische Chemie
Further development of antimicrobial lipopeptides: Optimization of pharmacokinetics, toxicity, and efficiency13:00 - 14:15 Lunch Break
Third Session from 14:15 - 16:05
Chair: Volkmar Vill, University of Hamburg14:15 - 14:40 Karsten Haupt, Compiègne University of Technology, CNRS Institute Enzyme and Cell Engineering, Compiegne
Biomimicry at the molecular level: Molecularly imprinted polymers as synthetic antibodies for bioimaging of cell surface glycans14:40 - 15:05 Clemens Möller, Fachhochschule Sigmaringen
Update on cardiac safety of peptides, and preliminary data on membrane effects15:05 - 15:30 Daniel Wilson, Universität Hamburg, Institut für Biochemie und Molekularbiologie
Intracellular mechanism of action of proline-rich antimicrobial peptides15:30 - 16:05 Friedrich von Wintzingerode, Roche Diagnostics, Penzberg
Low Endotoxin Recovery (LER). Endotoxin science challenges the pharmaceutical industry16:05 - 16:30 Coffee Break
Fourth Session from 16:30 - 17:45
Chair: Volkmar Vill, University of Hamburg16:30 - 16:55 Johanna Huchting, Universität Hamburg, Organische Chemie
Chemical and Metabolic Weaknesses of the Antiviral Favipiravir (T-705)16:55 - 17:20 Patrick Garidel, Martin-Luther-Universität Halle-Wittenberge
Techniques of inhalative application for combating respiratory infections17:20 - 17:45 Ann-Kathrin Desch, Volkmar Vill, Institut für Organische Chemie, Universität Hamburg
Vegetable tanning agents as colorants for cosmetic use18:30 - ? Get-together in the Rheinische Republik, Stadthausbrücke, Hamburg-City
Contact:
Prof. Dr. Volkmar Vill, University of Hamburg
Prof. Dr. Klaus Brandenburg, Brandenburg Antiinfektiva GmbH
Prof. Dr. Thomas Gutsmann, Forschungszentrum Borstel, Leibniz-Zentrum für Medizin und Biowissenschaften, Parkallee 10, D-23845 Borstel, Germany
E-mail: kbrandenburg"AT"fz-borstel.de